215 related articles for article (PubMed ID: 38089632)
1. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.
Buczyńska A; Kościuszko M; Krętowski AJ; Popławska-Kita A
Front Endocrinol (Lausanne); 2023; 14():1261860. PubMed ID: 38089632
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer.
Buczyńska A; Sidorkiewicz I; Kościuszko M; Adamska A; Siewko K; Dzięcioł J; Szumowski P; Myśliwiec J; Szelachowska M; Popławska-Kita A; Krętowski A
Sci Rep; 2023 Aug; 13(1):13711. PubMed ID: 37608150
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M; Besutti G; Mancuso P; Rossi PG; Ciarrocchi A; Donati B; Manzotti G; Giordano D; Frasoldati A; Chiaruccci F; de de Biase D; Coluccelli S; Maloberti T; De Leo A; Piana S; Tallini G
Histopathology; 2024 Mar; ():. PubMed ID: 38477417
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer via a Biomarker Panel Involving TAC, 8-OHdG and Sortilin.
Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38181425
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.
de Araujo-Filho VJ; Alves VA; de Castro IV; Lourenço SV; Cernea CR; Brandão LG; Ferraz AR
Thyroid; 2009 Nov; 19(11):1233-7. PubMed ID: 19888861
[TBL] [Abstract][Full Text] [Related]
6. Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.
Lopes NMD; Lens HHM; da Silva Brito WA; Bianchi JK; Marinello PC; Cecchini R; Armani A; Cecchini AL
Clin Transl Oncol; 2022 Dec; 24(12):2366-2378. PubMed ID: 35902455
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman - a case report.
Paulsson JO; Zedenius J; Juhlin CC
BMC Endocr Disord; 2018 Jul; 18(1):46. PubMed ID: 29976183
[TBL] [Abstract][Full Text] [Related]
8. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
9. Expression of Vascular Endothelial Growth Factor and Its Receptors in Thyroid Nodular Hyperplasia and Papillary Thyroid Carcinoma: A Tertiary Health Care Centre Based Study.
Mohamad Pakarul Razy NH; Wan Abdul Rahman WF; Win TT
Asian Pac J Cancer Prev; 2019 Jan; 20(1):277-282. PubMed ID: 30678450
[TBL] [Abstract][Full Text] [Related]
10. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
13. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
Jo YS; Li S; Song JH; Kwon KH; Lee JC; Rha SY; Lee HJ; Sul JY; Kweon GR; Ro HK; Kim JM; Shong M
J Clin Endocrinol Metab; 2006 Sep; 91(9):3667-70. PubMed ID: 16772349
[TBL] [Abstract][Full Text] [Related]
14. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
15. Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022.
Januś D; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Kujdowicz M; Czogała M; Górecki W; Starzyk JB
Front Endocrinol (Lausanne); 2023; 14():1170971. PubMed ID: 37274328
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics.
Shen K; Xiao S; Wu X; Zhang G
Front Endocrinol (Lausanne); 2022; 13():1025739. PubMed ID: 36277684
[TBL] [Abstract][Full Text] [Related]
17. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
18. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma.
Nam KH; Noh TW; Chung SH; Lee SH; Lee MK; Hong SW; Chung WY; Lee EJ; Park CS
Thyroid; 2011 Jul; 21(7):745-50. PubMed ID: 21615302
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
Tufano RP; Teixeira GV; Bishop J; Carson KA; Xing M
Medicine (Baltimore); 2012 Sep; 91(5):274-286. PubMed ID: 22932786
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Pathological Features and Gene Expression Profiles of Clinically Aggressive Papillary Thyroid Carcinomas.
Metovic J; Cabutti F; Osella-Abate S; Orlando G; Tampieri C; Napoli F; Maletta F; Daniele L; Volante M; Papotti M
Endocr Pathol; 2023 Sep; 34(3):298-310. PubMed ID: 37208504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
